Navigation Links
UT Public Health researchers find link to severe Staph infections
Date:12/23/2008

in the disease process. LukS-PV given through the nose protected the mice against pneumonia, conversely if administered subcutaneously it protected against skin infections.

Brown said, "The [vaccination] route and infection routes correlated with each other i.e., intranasally-immunized mice were better protected against pneumonia than subcutaneously vaccinated mice and subcutaneously-vaccinated mice were better protected against a skin infection than against pneumonia. This in part may be related to the type of immune response generated at the skin compared to the lung."

In addition, Brown and colleagues have examined the anti-PVL antibody responses in pediatric patients diagnosed with Staph infections compared to antibody responses to other USA300 virulence factors. The study found patients who had Staph infections caused by PVL-positive strains had a dominant response to the LukS and LukF proteins.


'/>"/>

Contact: Jade Waddy
jade.waddy@uth.tmc.edu
713-500-3307
University of Texas Health Science Center at Houston
Source:Eurekalert

Page: 1 2

Related biology news :

1. International public-private partnership offers new paradigm for medicinal chemistry
2. VCU survey: US public supports genetic research, testing and government spending on research
3. New national survey says public reveres bison
4. 2008 Ullyot Public Affairs Lecture
5. Bridging public and private research on bioinformatics and proteomics
6. Indiana University research at American Public Health Association meeting
7. BIO-key(R) Announces Additional $245,000 in Third Quarter Public Safety Orders
8. Stevens strengthens Dominican Republics Early Warning System for Inundations
9. American Physical Society announces Physics, a new, free, online publication
10. FAS honors Mark D. Levine with 2008 Public Service Award
11. Healthy Minds Across America features 48 public forums on mental health research, Sept. 14
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)... could become the source of more of humanity,s food ... aquaculture, according to a study published in the December ... world,s population continues to grow, lack of fresh water ... be able to meet food demand, according to Carlos ... Spain, and his seven coauthors. Freshwater aquaculture, which is ...
(Date:12/5/2009)... the exhaustive research into venom produced by snakes and ... of a mystery. Now, a study of 158 catfish ... Evolutionary Biology , has catalogued the presence of venom ... Jeremy Wright, from the University of Michigan, USA, carried ... toxicological techniques to elucidate the diversity and distribution of ...
(Date:12/4/2009)... a battle zone. Cells constantly compete with one another for ... win this competition is well known to be the survival ... space and survival is not as clear. A study on ... Science by Johns Hopkins researchers describes how stem cells ...
Breaking Biology News(10 mins):Stem cells battle for space 2Scientists discover new genetic immune disorder in children 8716 1Scientists discover new genetic immune disorder in children 8716 2Scientists discover new genetic immune disorder in children 8716 3Shock and kill research gives new hope for HIV 1 eradication 8714 1Shock and kill research gives new hope for HIV 1 eradication 8714 2New Option for Erasing Wrinkles 47913 1New Option for Erasing Wrinkles 47913 2New Option for Erasing Wrinkles 47913 3New Option for Erasing Wrinkles 47913 4
... link between water pollution and rising male fertility problems. ... and Reading and the Centre for Ecology & Hydrology, ... testosterone-blocking chemicals is finding its way into UK rivers, ... by the Natural Environment Research Council and is now ...
... Until credible sightings popped up three years ago, the scientific ... way of the dodo. A new study conducted by University ... persisted if as few as five mated pairs survived the ... published in the online journal Avian Conservation and Ecology ...
... of scientists has solved a mystery that has puzzled ... contribute a significant fraction of the oceans, calcium carbonate ... The study gives a conservative estimate of three to ... fish, but the researchers believe it could be up ...
Other Biology News:Study links water pollution with declining male fertility 2Study links water pollution with declining male fertility 3UGA study may give hope that ivory-billed woodpeckers still around 2UGA study may give hope that ivory-billed woodpeckers still around 3Fishdunnit! Mystery solved 2Fishdunnit! Mystery solved 3
(Date:12/6/2009)... Conn., Dec. 6 Boehringer Ingelheim today ... etexilate (150 mg BID), a direct thrombin inhibitor ... acute VTE. Results of the trial were ... Annual Meeting and simultaneously published online in the ... ,, Dabigatran etexilate met the primary outcome of ...
(Date:12/4/2009)... Technology (NIST) and the Naval Research Laboratory have developed ... semiconductor crystal by prodding it with a scanning tunneling ... will enable researchers to selectively implant atoms in a ... electrical and magnetic properties on the atomic scale. , ...
(Date:12/4/2009)... Iowa, Dec. 4 Vivakor, Inc. (OTC Bulletin Board: ... December 1, 2009 will receive the dividend of shares ... approved by Vivakor,s Board of Directors. HealthAmerica is ... 84% of the outstanding common shares on the record ...
(Date:12/4/2009)... Advanced Micro Nano Technology Products (ACAMP) hosts, ... Dec. 4 /PRNewswire/ - Today ACAMP hosted a ... nanotechnology, biomaterials and microfluidics can play a powerful ... that help promote health and improve the quality, ...
Breaking Biology Technology:RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 2RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 3RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 4RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 5RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 6NIST researchers put a new spin on atomic musical chairs 2Vivakor Confirms Record Date of Stock Dividend 2Vivakor Confirms Record Date of Stock Dividend 3Alberta companies delivering new products to the health & medical marketplace 2
... WASHINGTON, Oct. 19 Interventional cardiologists,operate in ... such face many challenges,in the provision of ... the use of drug-eluting versus bare metal ... are among these changes.,Further, recently released ACC/AHA ...
... by James Cornelius, CEO of Bristol-Myers Squibb, ... Life Sciences, an,emerging specialty pharmaceutical company focused ... development and commercialization of treatments,for diseased and ... the Company,s President and Chief Executive Officer, ...
... VANCOUVER, Oct. 19 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals,Inc. ... global specialty pharmaceutical and,medical device company, today ... ended September 30, 2007 and updated its ... 31, 2007, in conjunction with the,release of ...
Other Biology Technology:Free CME-certified Webcast: Making Your Case: Up-to-date Answers for Developing Trends in PCI 2Free CME-certified Webcast: Making Your Case: Up-to-date Answers for Developing Trends in PCI 3Cutanea to Present at the Paramount BioSciences Healthcare Conference 2Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 2Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 3Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 4Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 5Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 6Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 7Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 8Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 9Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 10Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 11
GenomePlex Whole Genome Amplification (WGA) kit from Sigma-Aldrich
FluoroGuard Antifade Reagent from Bio-Rad
...n: The greater incorporation of Br-dUTP results in... using a fluorescein-labeled anti-BrdU antibody. ...he kit to counterstain the total DNA. Features and...ting in improved detection than found by using bio...
Mouse Anti-Human FBXO24 Monoclonal Antibody, Unconjugated, Clone 7F12 from Abnova Corporation
Biology Products: